Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic disease

Objectives A timely diagnosis is imperative for curing cancer. However, in patients with rheumatic musculoskeletal diseases (RMDs) or paraneoplastic syndromes, misleading symptoms frequently delay cancer diagnosis. As metabolic remodelling characterises both cancer and RMD, we analysed if a metaboli...

Full description

Saved in:
Bibliographic Details
Main Authors: Gente, Karolina (Author) , Feißt, Manuel (Author) , Marx, Dorothea (Author) , Klika, Karel D. (Author) , Christopoulos, Petros (Author) , Graf, Jürgen (Author) , Will, Julia (Author) , Luft, Thomas (Author) , Hassel, Jessica C. (Author) , Müller-Tidow, Carsten (Author) , Carvalho, Rui A. (Author) , Lorenz, Hanns-Martin (Author) , Souto-Carneiro, Maria Margarida (Author)
Format: Article (Journal)
Language:English
Published: 1 April 2024
In: Annals of the rheumatic diseases
Year: 2024, Volume: 83, Issue: 8, Pages: 974-983
ISSN:1468-2060
DOI:10.1136/ard-2023-224839
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1136/ard-2023-224839
Verlag, kostenfrei, Volltext: https://ard.bmj.com/content/early/2024/04/01/ard-2023-224839
Get full text
Author Notes:Karolina Gente, Manuel Feisst, Dorothea Marx, Karel D. Klika, Petros Christopoulos, Jürgen Graf, Julia Will, Thomas Luft, Jessica C. Hassel, Carsten Müller-Tidow, Rui A. Carvalho, Hanns-Martin Lorenz, M. Margarida Souto-Carneiro

MARC

LEADER 00000caa a2200000 c 4500
001 1890520810
003 DE-627
005 20240730110112.0
007 cr uuu---uuuuu
008 240603s2024 xx |||||o 00| ||eng c
024 7 |a 10.1136/ard-2023-224839  |2 doi 
035 |a (DE-627)1890520810 
035 |a (DE-599)KXP1890520810 
035 |a (OCoLC)1443679399 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Gente, Karolina  |d 1986-  |e VerfasserIn  |0 (DE-588)1066617481  |0 (DE-627)817734120  |0 (DE-576)426070216  |4 aut 
245 1 0 |a Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic disease  |c Karolina Gente, Manuel Feisst, Dorothea Marx, Karel D. Klika, Petros Christopoulos, Jürgen Graf, Julia Will, Thomas Luft, Jessica C. Hassel, Carsten Müller-Tidow, Rui A. Carvalho, Hanns-Martin Lorenz, M. Margarida Souto-Carneiro 
264 1 |c 1 April 2024 
300 |b Illustrationen 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 03.06.2024 
520 |a Objectives A timely diagnosis is imperative for curing cancer. However, in patients with rheumatic musculoskeletal diseases (RMDs) or paraneoplastic syndromes, misleading symptoms frequently delay cancer diagnosis. As metabolic remodelling characterises both cancer and RMD, we analysed if a metabolic signature can indicate paraneoplasia (PN) or reveal concomitant cancer in patients with RMD. - Methods Metabolic alterations in the sera of rheumatoid arthritis (RA) patients with (n=56) or without (n=52) a history of invasive cancer were quantified by nuclear magnetic resonance analysis. Metabolites indicative of cancer were determined by multivariable regression analyses. Two independent RA and spondyloarthritis (SpA) cohorts with or without a history of invasive cancer were used for blinded validation. Samples from patients with active cancer or cancer treatment, pulmonary and lymphoid type cancers, paraneoplastic syndromes, non-invasive (NI) precancerous lesions and non-melanoma skin cancer and systemic lupus erythematosus and samples prior to the development of malignancy were used to test the model performance. - Results Based on the concentrations of acetate, creatine, glycine, formate and the lipid ratio L1/L6, a diagnostic model yielded a high sensitivity and specificity for cancer diagnosis with AUC=0.995 in the model cohort, AUC=0.940 in the blinded RA validation cohort and AUC=0.928 in the mixed RA/SpA cohort. It was equally capable of identifying cancer in patients with PN. The model was insensitive to common demographic or clinical confounders or the presence of NI malignancy like non-melanoma skin cancer. - Conclusions This new set of metabolic markers reliably predicts the presence of cancer in arthritis or PN patients with high sensitivity and specificity and has the potential to facilitate a rapid and correct diagnosis of malignancy. 
650 4 |a Lipids 
650 4 |a Machine Learning 
650 4 |a Rheumatoid Arthritis 
650 4 |a Spondylitis, Ankylosing 
700 1 |a Feißt, Manuel  |d 1989-  |e VerfasserIn  |0 (DE-588)1158520948  |0 (DE-627)1020533544  |0 (DE-576)504012312  |4 aut 
700 1 |a Marx, Dorothea  |d 1997-  |e VerfasserIn  |0 (DE-588)1331516374  |0 (DE-627)1890519723  |4 aut 
700 1 |a Klika, Karel D.  |e VerfasserIn  |4 aut 
700 1 |a Christopoulos, Petros  |d 1977-  |e VerfasserIn  |0 (DE-588)138659702  |0 (DE-627)604886756  |0 (DE-576)308488067  |4 aut 
700 1 |a Graf, Jürgen  |d 1975-  |e VerfasserIn  |0 (DE-588)132485699  |0 (DE-627)522960065  |0 (DE-576)299176142  |4 aut 
700 1 |a Will, Julia  |e VerfasserIn  |0 (DE-588)1311319336  |0 (DE-627)1871297338  |4 aut 
700 1 |a Luft, Thomas  |e VerfasserIn  |0 (DE-588)1078976309  |0 (DE-627)839996969  |0 (DE-576)452120659  |4 aut 
700 1 |a Hassel, Jessica C.  |d 1975-  |e VerfasserIn  |0 (DE-588)129790702  |0 (DE-627)480399069  |0 (DE-576)29783715X  |4 aut 
700 1 |a Müller-Tidow, Carsten  |d 1968-  |e VerfasserIn  |0 (DE-588)1015101798  |0 (DE-627)705330230  |0 (DE-576)351197893  |4 aut 
700 1 |a Carvalho, Rui A.  |e VerfasserIn  |4 aut 
700 1 |a Lorenz, Hanns-Martin  |d 1962-  |e VerfasserIn  |0 (DE-588)112253865  |0 (DE-627)627277845  |0 (DE-576)167601369  |4 aut 
700 1 |a Souto-Carneiro, Maria Margarida  |d 1973-  |e VerfasserIn  |0 (DE-588)122890698  |0 (DE-627)082217696  |0 (DE-576)293465649  |4 aut 
773 0 8 |i Enthalten in  |t Annals of the rheumatic diseases  |d [Amsterdam] : Elsevier, 1939  |g 83(2024), 8, Seite 974-983  |w (DE-627)300184999  |w (DE-600)1481557-6  |w (DE-576)078941237  |x 1468-2060  |7 nnas  |a Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic disease 
773 1 8 |g volume:83  |g year:2024  |g number:8  |g pages:974-983  |g extent:10  |a Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic disease 
856 4 0 |u https://doi.org/10.1136/ard-2023-224839  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://ard.bmj.com/content/early/2024/04/01/ard-2023-224839  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20240603 
993 |a Article 
994 |a 2024 
998 |g 122890698  |a Souto-Carneiro, Maria Margarida  |m 122890698:Souto-Carneiro, Maria Margarida  |d 910000  |d 910100  |e 910000PS122890698  |e 910100PS122890698  |k 0/910000/  |k 1/910000/910100/  |p 13  |y j 
998 |g 112253865  |a Lorenz, Hanns-Martin  |m 112253865:Lorenz, Hanns-Martin  |d 910000  |d 910100  |e 910000PL112253865  |e 910100PL112253865  |k 0/910000/  |k 1/910000/910100/  |p 12 
998 |g 1015101798  |a Müller-Tidow, Carsten  |m 1015101798:Müller-Tidow, Carsten  |d 910000  |d 910100  |e 910000PM1015101798  |e 910100PM1015101798  |k 0/910000/  |k 1/910000/910100/  |p 10 
998 |g 129790702  |a Hassel, Jessica C.  |m 129790702:Hassel, Jessica C.  |d 910000  |d 911300  |d 50000  |e 910000PH129790702  |e 911300PH129790702  |e 50000PH129790702  |k 0/910000/  |k 1/910000/911300/  |k 0/50000/  |p 9 
998 |g 1078976309  |a Luft, Thomas  |m 1078976309:Luft, Thomas  |d 910000  |d 910100  |d 50000  |e 910000PL1078976309  |e 910100PL1078976309  |e 50000PL1078976309  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 8 
998 |g 1311319336  |a Will, Julia  |m 1311319336:Will, Julia  |d 50000  |e 50000PW1311319336  |k 0/50000/  |p 7 
998 |g 132485699  |a Graf, Jürgen  |m 132485699:Graf, Jürgen  |d 120000  |d 120100  |e 120000PG132485699  |e 120100PG132485699  |k 0/120000/  |k 1/120000/120100/  |p 6 
998 |g 138659702  |a Christopoulos, Petros  |m 138659702:Christopoulos, Petros  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PC138659702  |e 950000PC138659702  |e 950900PC138659702  |e 50000PC138659702  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 5 
998 |g 1331516374  |a Marx, Dorothea  |m 1331516374:Marx, Dorothea  |d 50000  |e 50000PM1331516374  |k 0/50000/  |p 3 
998 |g 1158520948  |a Feißt, Manuel  |m 1158520948:Feißt, Manuel  |d 910000  |d 911800  |e 910000PF1158520948  |e 911800PF1158520948  |k 0/910000/  |k 1/910000/911800/  |p 2 
998 |g 1066617481  |a Gente, Karolina  |m 1066617481:Gente, Karolina  |d 910000  |d 910100  |e 910000PG1066617481  |e 910100PG1066617481  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1890520810  |e 4533809650 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.1136/ard-2023-224839"],"eki":["1890520810"]},"name":{"displayForm":["Karolina Gente, Manuel Feisst, Dorothea Marx, Karel D. Klika, Petros Christopoulos, Jürgen Graf, Julia Will, Thomas Luft, Jessica C. Hassel, Carsten Müller-Tidow, Rui A. Carvalho, Hanns-Martin Lorenz, M. Margarida Souto-Carneiro"]},"recId":"1890520810","physDesc":[{"noteIll":"Illustrationen","extent":"10 S."}],"title":[{"title":"Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic disease","title_sort":"Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic disease"}],"note":["Gesehen am 03.06.2024"],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"display":"Gente, Karolina","role":"aut","given":"Karolina","family":"Gente"},{"family":"Feißt","role":"aut","given":"Manuel","display":"Feißt, Manuel"},{"display":"Marx, Dorothea","given":"Dorothea","role":"aut","family":"Marx"},{"given":"Karel D.","role":"aut","family":"Klika","display":"Klika, Karel D."},{"family":"Christopoulos","given":"Petros","role":"aut","display":"Christopoulos, Petros"},{"given":"Jürgen","role":"aut","family":"Graf","display":"Graf, Jürgen"},{"given":"Julia","role":"aut","family":"Will","display":"Will, Julia"},{"given":"Thomas","role":"aut","family":"Luft","display":"Luft, Thomas"},{"display":"Hassel, Jessica C.","role":"aut","given":"Jessica C.","family":"Hassel"},{"display":"Müller-Tidow, Carsten","given":"Carsten","role":"aut","family":"Müller-Tidow"},{"given":"Rui A.","role":"aut","family":"Carvalho","display":"Carvalho, Rui A."},{"role":"aut","given":"Hanns-Martin","family":"Lorenz","display":"Lorenz, Hanns-Martin"},{"display":"Souto-Carneiro, Maria Margarida","role":"aut","given":"Maria Margarida","family":"Souto-Carneiro"}],"relHost":[{"title":[{"title":"Annals of the rheumatic diseases","title_sort":"Annals of the rheumatic diseases","subtitle":"the EULAR journal"}],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 24.01.2025","Beteil. Urh. teils: British Medical Association"],"origin":[{"publisher":"Elsevier ; BMJ Publ. Group","publisherPlace":"[Amsterdam] ; London","dateIssuedKey":"2025","dateIssuedDisp":"2025-"}],"disp":"Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic diseaseAnnals of the rheumatic diseases","recId":"300184999","id":{"issn":["1468-2060"],"eki":["300184999"],"zdb":["1481557-6"]},"part":{"volume":"83","year":"2024","issue":"8","extent":"10","text":"83(2024), 8, Seite 974-983","pages":"974-983"},"name":{"displayForm":["European Alliance of Associations for Rheumatology (EULAR)"]},"titleAlt":[{"title":"ARD"}],"pubHistory":["1.1939 -"],"corporate":[{"role":"isb","display":"European League against Rheumatism"},{"display":"British Medical Association","role":"isb"}]}],"origin":[{"dateIssuedDisp":"1 April 2024","dateIssuedKey":"2024"}]} 
SRT |a GENTEKAROLALTEREDSER1202